Women's Imaging

More than 50% of the 43.7 million foreign-born people living in the U.S. are female—that figure is only expected to grow, explained lead author Tainya Clarke, PhD, MPH.

An algorithm designed to unfold MRI scans of the placenta may allow doctors to more accurately identify and treat issues with the organ during pregnancy, according to new research out of MIT’s Computer Science and Artificial Intelligence Laboratory.

“Knowing that the cancer yield of screening US is similar after DBT versus DM may help inform clinical practice, because questions abound about whether DBT is sufficient screening for women with dense breast tissue," wrote authors of a new study published in the American Journal of Roentgenology.

Using contrast-enhanced digital mammography (CEDM) to evaluate low to moderately suspicious breast lesions can greatly reduce biopsies in patients with benign lesions, according to a study published Sept. 5 in Academic Radiology.

The U.S. Preventative Services Task Force (USPSTF) released updated recommendations for BRCA1/2 testing, suggesting practitioners increase the use of genetic counseling and testing.

New research published in Radiology has found that screening mammography use is highest in coastal cities, while cities within mountain states are lagging behind.

More women are exposed to gadolinium-based contrast agents (GBCAs) in their first trimester compared to the later weeks of pregnancy, according to an Aug. 20 study published in Radiology. But some experts warn this information should not lead to drastic conclusions.

Synthesized digital mammography (SM) was created to help reduce the radiation dose for patients undergoing digital mammography (DM) in digital breast tomosynthesis (DBT), so why haven’t more clinics adopted it?

There’s a strong case to be made for mammography to become a “dual test” for both breast cancer screening and cardiovascular disease (CVD) prevention, according to a new review published in the European Journal of Radiology.

Breast cancer screening using digital breast tomosynthesis has risen rapidly in the United States, but that isn’t the case in all regions or across all institutions, according to a new study published in Current Problems in Diagnostic Radiology.

Although most studies demonstrating the benefits of digital breast tomosynthesis (DBT) have been observational, use of the modality has risen dramatically over the past few years, according to a study of more than nine million women published in JAMA Internal Medicine.

“In a scenario where double reading at screening mammography is not available…we believe that the use of this model as a second reader could be beneficial,” wrote researchers in a new study published by Radiology.